A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control E Bodó, T Bíró, A Telek, G Czifra, Z Griger, BI Tóth, A Mescalchin, T Ito, ... The American journal of pathology 166 (4), 985-998, 2005 | 247 | 2005 |
Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome E Zilahi, T Tarr, G Papp, Z Griger, S Sipka, M Zeher Immunology letters 141 (2), 165-168, 2012 | 151 | 2012 |
Four dermatomyositis-specific autoantibodies—anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5—in adult and juvenile patients with idiopathic inflammatory myopathies in a … L Bodoki, M Nagy-Vincze, Z Griger, Z Betteridge, L Szöllősi, K Dankó Autoimmunity reviews 13 (12), 1211-1219, 2014 | 113 | 2014 |
Transient receptor potential vanilloid-1 signaling as a regulator of human sebocyte biology BI Tóth, T Géczy, Z Griger, A Dózsa, H Seltmann, L Kovács, L Nagy, ... Journal of Investigative Dermatology 129 (2), 329-339, 2009 | 100 | 2009 |
Trial of intravenous immune globulin in dermatomyositis R Aggarwal, C Charles-Schoeman, J Schessl, Z Bata-Csörgő, ... New England Journal of Medicine 387 (14), 1264-1278, 2022 | 80 | 2022 |
C1-inhibitor autoantibodies in SLE T Mészáros, G Füst, H Farkas, L Jakab, G Temesszentandrási, G Nagy, ... Lupus 19 (5), 634-638, 2010 | 64 | 2010 |
Retrospective analysis of cancer-associated myositis patients over the past 3 decades in a Hungarian myositis cohort C András, L Bodoki, M Nagy-Vincze, Z Griger, E Csiki, K Dankó Pathology & Oncology Research 26, 1749-1755, 2020 | 42 | 2020 |
Pharmacological management of dermatomyositis Z Griger, M Nagy-Vincze, K Dankó Expert Review of Clinical Pharmacology 10 (10), 1109-1118, 2017 | 28 | 2017 |
Abnormal Cell‐Specific Expressions of Certain Protein Kinase C Isoenzymes in Peripheral Mononuclear Cells of Patients with Systemic Lupus Erythematosus: Effect of … T Bíró, Z Griger, E Kiss, H Papp, M Aleksza, I Kovács, M Zeher, E Bodolay, ... Scandinavian journal of immunology 60 (4), 421-428, 2004 | 27 | 2004 |
Dysregulated expression profile of myomiRs in the skeletal muscle of patients with polymyositis E Zilahi, Z Adamecz, L Bodoki, Z Griger, S Póliska, M Nagy-Vincze, ... Ejifcc 30 (2), 237, 2019 | 25 | 2019 |
Platelet microparticles enriched in miR-223 reduce ICAM-1-dependent vascular inflammation in septic conditions B Szilágyi, Z Fejes, Á Rusznyák, F Fenyvesi, M Pócsi, S Halmi, Z Griger, ... Frontiers in Physiology 12, 658524, 2021 | 23 | 2021 |
Pruritus: a sensory symptom generated in cutaneous immuno-neuronal crosstalk AG Szöllősi, A Oláh, E Lisztes, Z Griger, BI Tóth Frontiers in Pharmacology 13, 745658, 2022 | 16 | 2022 |
Vitamin D receptor gene polymorphisms and haplotypes in Hungarian patients with idiopathic inflammatory myopathy L Bodoki, JQ Chen, M Zeher, M Nagy-Vincze, Z Griger, E Zilahi, K Dankó BioMed Research International 2015 (1), 809895, 2015 | 15 | 2015 |
Effect of genetic and laboratory findings on clinical course of antisynthetase syndrome in a Hungarian cohort K Szabó, L Bodoki, M Nagy-Vincze, A Vincze, E Zilahi, P Szodoray, ... BioMed Research International 2018 (1), 6416378, 2018 | 14 | 2018 |
The in vitro treatment with vitamin D3 is ineffective on the expression of PKC isoenzymes, but decreases further the impaired production of IL-2 in the T lymphocytes … G Czifra, B Tóth, I Kovács, T Bíró, Z Griger, S Baráth, T Tarr, M Zeher, ... Rheumatology international 34, 717-720, 2014 | 14 | 2014 |
Protein kinase C-β and-δ isoenzymes promote arachidonic acid production and proliferation of MonoMac-6 cells Z Griger, E Páyer, I Kovács, BI Tóth, L Kovács, S Sipka, T Bíró Journal of Molecular Medicine 85, 1031-1042, 2007 | 14 | 2007 |
The risk of fracture and prevalence of osteoporosis is elevated in patients with idiopathic inflammatory myopathies: cross-sectional study from a single Hungarian center A Vincze, L Bodoki, K Szabó, M Nagy-Vincze, O Szalmás, J Varga, ... BMC Musculoskeletal Disorders 21, 1-8, 2020 | 11 | 2020 |
Efficacy and safety of IVIg (octagam 10%) in patients with active dermatomyositis. Results of a randomized, double-blind, placebo-controlled phase III trial (ProDERM study) R Aggarwal, C Charles-Schoeman, J Schessl, Z Bata-Csorgo, ... ARTHRITIS & RHEUMATOLOGY 72, 2020 | 9 | 2020 |
Late onset dysferlinopathy mimicking treatment resistant polymyositis. Z Griger, M Nagy-Vincze, L Bodoki, RK Gherardi, K Dankó, T Hortobágyi Joint Bone Spine 83 (3), 355-356, 2015 | 8 | 2015 |
Description of patients with IgG4-related disease from a Hungarian centre A Szántó, G Nagy, CS Molnár, Z Griger, T Tarr, M Zeher Scandinavian Journal of Rheumatology 43 (4), 334-337, 2014 | 8 | 2014 |